139 related articles for article (PubMed ID: 24447412)
1. Facilitating women's access to misoprostol through community-based advocacy in Kenya and Tanzania.
Coeytaux F; Hessini L; Ejano N; Obbuyi A; Oguttu M; Osur J; Shuken K
Int J Gynaecol Obstet; 2014 Apr; 125(1):53-5. PubMed ID: 24447412
[TBL] [Abstract][Full Text] [Related]
2. Women's abortion seeking behavior under restrictive abortion laws in Mexico.
Juarez F; Bankole A; Palma JL
PLoS One; 2019; 14(12):e0226522. PubMed ID: 31881041
[TBL] [Abstract][Full Text] [Related]
3. Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study.
Reiss K; Footman K; Burke E; Diop N; Ndao R; Mane B; van Min M; Ngo TD
BMC Pregnancy Childbirth; 2017 Jul; 17(1):211. PubMed ID: 28673342
[TBL] [Abstract][Full Text] [Related]
4. Community-based distribution of misoprostol for early abortion: evaluation of a program along the Thailand-Burma border.
Foster AM; Arnott G; Hobstetter M
Contraception; 2017 Oct; 96(4):242-247. PubMed ID: 28651904
[TBL] [Abstract][Full Text] [Related]
5. Provision of harm-reduction services to limit unsafe abortion in Tanzania.
Kahabuka C; Pembe A; Meglioli A
Int J Gynaecol Obstet; 2017 Feb; 136(2):210-214. PubMed ID: 28099731
[TBL] [Abstract][Full Text] [Related]
6. A Pill in the Lifeworld of Women in Burkina Faso: Can Misoprostol Reframe the Meaning of Abortion.
Drabo S
Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31718106
[TBL] [Abstract][Full Text] [Related]
7. Availability and prescription of misoprostol for medical abortion in community pharmacies and associated factors in Accra, Ghana.
Ganle JK; Busia NT; Maya E
Int J Gynaecol Obstet; 2019 Feb; 144(2):167-173. PubMed ID: 30451283
[TBL] [Abstract][Full Text] [Related]
8. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania.
Shwekerela B; Kalumuna R; Kipingili R; Mashaka N; Westheimer E; Clark W; Winikoff B
BJOG; 2007 Nov; 114(11):1363-7. PubMed ID: 17803714
[TBL] [Abstract][Full Text] [Related]
9. "It is just like having a period with back pain": exploring women's experiences with community-based distribution of misoprostol for early abortion on the Thailand-Burma border.
Tousaw E; Moo SNHG; Arnott G; Foster AM
Contraception; 2018 Feb; 97(2):122-129. PubMed ID: 28780239
[TBL] [Abstract][Full Text] [Related]
10. Physicians' approaches to post-abortion care in Manila, Philippines.
Cansino C; Melgar JL; Burke A
Int J Gynaecol Obstet; 2010 Jun; 109(3):216-8. PubMed ID: 20176351
[TBL] [Abstract][Full Text] [Related]
11. Commercial availability of misoprostol and induced abortion in Brazil.
Costa SH
Int J Gynaecol Obstet; 1998 Dec; 63 Suppl 1():S131-9. PubMed ID: 10075223
[TBL] [Abstract][Full Text] [Related]
12. Women's experiences with the use of medical abortion in a legally restricted context: the case of Argentina.
Ramos S; Romero M; Aizenberg L
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):4-15. PubMed ID: 25702064
[TBL] [Abstract][Full Text] [Related]
13. WHO recommendations for misoprostol use for obstetric and gynecologic indications.
Tang J; Kapp N; Dragoman M; de Souza JP
Int J Gynaecol Obstet; 2013 May; 121(2):186-9. PubMed ID: 23433680
[TBL] [Abstract][Full Text] [Related]
14. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
15. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions.
Aldrich T; Winikoff B
BJOG; 2007 May; 114(5):555-62. PubMed ID: 17439563
[TBL] [Abstract][Full Text] [Related]
16. Opening a door to safe abortion: international perspectives on medical abortifacient use.
Pollack AE; Pine RN
J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):186-8. PubMed ID: 10846335
[TBL] [Abstract][Full Text] [Related]
17. A case study of community-based distribution and use of Misoprostol and Chlorhexidine in Sokoto State, Nigeria.
Cannon M; Charyeva Z; Oguntunde O; Sambisa W; Shoretire K; Orobaton N
Glob Public Health; 2017 Dec; 12(12):1553-1567. PubMed ID: 27100376
[TBL] [Abstract][Full Text] [Related]
18. [Misoprostol off label essential for women's health].
Danielsson KG
Lakartidningen; 2013 Nov 13-19; 110(46):2045-6. PubMed ID: 24380157
[No Abstract] [Full Text] [Related]
19. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
[TBL] [Abstract][Full Text] [Related]
20. Safe abortion information hotlines: An effective strategy for increasing women's access to safe abortions in Latin America.
Drovetta RI
Reprod Health Matters; 2015 May; 23(45):47-57. PubMed ID: 26278832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
